Literature DB >> 11880111

Detection of human papillomavirus DNA by PCR/microfluorometry for screening of cervical cancer.

Akihiro Yamaguchi1, Naoko Hashimoto, Wataru Tsutae, Kuniyoshi Seino, Yasuhiko Ebina, Takashi Tokino, Noriyuki Sato, Kokichi Kikuchi.   

Abstract

BACKGROUND: Cervical cancer screening is conducted by a cytological Papanicolaou (Pap) test. For screening, it is becoming increasingly important to introduce a more objective result, based on human papillomavirus (HPV) DNA test. We describe here a practical method allowing the mass detection of HPV-DNA by PCR followed by fluorogenic DNA intercalation.
METHODS: Samples used were cervical scrapes or biopsy specimens obtained from women who had undergone cytological testing for cervical cancer. Crude DNAs were extracted by a simplified proteinase K-boil method. Common and type-specific primers were newly designed for major types of high-risk HPVs. A fluorogenic DNA intercalator, SYBR Green I was directly added to the specific PCR products. The resultant fluorescence was measured by a conventional fluorometric microplate reader.
RESULTS: The proposed PCR/microfluorometry (MFL) allowed a simple, rapid and economical detection of HPV-DNA without any use of labeling primers or probes. HPV-DNAs were found in 48.2% (123/255) of the cervical scrapes. The detection rate of HPV in cervical cancer biopsy specimen was 92.4% (61/66).
CONCLUSIONS: PCR/MFL detection of HPV-DNA, followed by combined type-specific PCR, is expected to be an extremely useful tool in cervical cancer screening.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11880111     DOI: 10.1016/s0009-8981(01)00795-1

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  1 in total

1.  Clinical, laboratory and epidemiological aspects of HPV infection in a low-income population from South Bahia, Brazil.

Authors:  S R Gadelha; D M V Soares-Barreto; G B Costa; V C N Leal; L G S Gomes; U R Santos; G C S Ferreira; L D Carvalho; S M V Soraes-Almeida; M A G Mello; A P M Mariano; S M B Sousa; A R Vago; L J Marin
Journal:  Epidemiol Infect       Date:  2017-11-23       Impact factor: 4.434

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.